| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |